Folgen
Vigneshwaran Namasivayam
Vigneshwaran Namasivayam
Dewpoint Therapeutics
Bestätigte E-Mail-Adresse bei uni-bonn.de
Titel
Zitiert von
Zitiert von
Jahr
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
T Pillaiyar, M Manickam, V Namasivayam
Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 403-425, 2017
9402017
An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
T Pillaiyar, M Manickam, V Namasivayam, Y Hayashi, SH Jung
Journal of medicinal chemistry 59 (14), 6595-6628, 2016
8282016
Inhibitors of Melanogenesis: An Updated Review
T Pillaiyar, V Namasivayam, M Manickam, SH Jung
Journal of medicinal chemistry 61 (17), 7395-7418, 2018
3082018
The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic
V Namasivayam, M Vanangamudi, VG Kramer, S Kurup, P Zhan, X Liu, ...
Journal of medicinal chemistry 62 (10), 4851-4883, 2018
1682018
Overview of recent strategic advances in medicinal chemistry
G Wu, T Zhao, D Kang, J Zhang, Y Song, V Namasivayam, J Kongsted, ...
Journal of medicinal chemistry 62 (21), 9375-9414, 2019
1542019
PSO@ Autodock: A fast flexible molecular docking program based on swarm intelligence
V Namasivayam, R Günther
Chemical biology & drug design 70 (6), 475-484, 2007
1512007
Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
J Breidenbach, C Lemke, T Pillaiyar, L Schäkel, G Al Hamwi, M Diett, ...
Angewandte Chemie International Edition 60 (18), 10423-10429, 2021
1242021
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies
A Abdelrahman, V Namasivayam, S Hinz, AC Schiedel, M Köse, M Burton, ...
Biochemical Pharmacology 125, 41-54, 2017
702017
Structure–Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors
A Junker, C Renn, C Dobelmann, V Namasivayam, S Jain, K Losenkova, ...
Journal of medicinal chemistry 62 (7), 3677-3695, 2019
642019
The promiscuous ectonucleotidase NPP1: molecular insights into substrate binding and hydrolysis
V Namasivayam, SY Lee, CE Mueller
Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (3), 603-614, 2017
572017
Agonists and antagonists for purinergic receptors
CE Müller, Y Baqi, V Namasivayam
Purinergic signaling: Methods and protocols, 45-64, 2020
552020
Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor
M Rafehi, EM Malik, A Neumann, A Abdelrahman, T Hanck, ...
Journal of Medicinal Chemistry 60 (7), 3020-3038, 2017
502017
2, 4, 6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2
MK Krapf, J Gallus, V Namasivayam, M Wiese
Journal of medicinal chemistry 61 (17), 7952-7976, 2018
432018
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor
M Rafehi, A Neumann, Y Baqi, EM Malik, M Wiese, V Namasivayam, ...
Journal of medicinal chemistry 60 (20), 8425-8440, 2017
422017
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
M Vanangamudi, S Kurup, V Namasivayam
Current Opinion in Pharmacology 54, 179-187, 2020
412020
Fluorescent-Labeled Selective Adenosine A2B Receptor Antagonist Enables Competition Binding Assay by Flow Cytometry
M Kose, S Gollos, T Karcz, A Fiene, F Heisig, A Behrenswerth, ...
Journal of medicinal chemistry 61 (10), 4301-4316, 2018
402018
Substrate-dependence of competitive nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors
SY Lee, S Sarkar, S Bhattarai, V Namasivayam, S De Jonghe, H Stephan, ...
Frontiers in Pharmacology 8, 54, 2017
402017
MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs
G Al Hamwi, YK Riedel, S Clemens, V Namasivayam, D Thimm, ...
Pharmacology & Therapeutics 238, 108259, 2022
392022
Cancer cells adapt FAM134B/BiP mediated ER-phagy to survive hypoxic stress
S Chipurupalli, R Ganesan, G Martini, L Mele, A Reggio, M Esposito, ...
Cell Death & Disease 13 (4), 357, 2022
382022
Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359
C Hermes, R Richarz, DA Wirtz, J Patt, W Hanke, S Kehraus, JH Voß, ...
Nature communications 12 (1), 144, 2021
382021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20